Beneficial Hemodynamic Effects of Oral Levodopa in Heart Failure
- 24 May 1984
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 310 (21), 1357-1362
- https://doi.org/10.1056/nejm198405243102105
Abstract
Among the positive inotropic drugs available to improve myocardial contractility in congestive heart failure, only digitalis glycosides are suitable for oral administration. In this study, we administered oral levodopa (1.5 to 2.0 g), which is decarboxylated to form dopamine, to 10 patients with severe congestive heart failure. Peak hemodynamic responses occurred one hour after the ingestion of levodopa, with the mean (±S.E.M.) cardiac index increasing from 1.8±0.1 to 2.4 ± 0.2 liters per minute per square meter of body-surface area (P-5 (P1-adrenergic, dopamine1, and dopamine2 receptors by dopamine derived from levodopa. (N Engl J Med 1984; 310:1357–62.)This publication has 19 references indexed in Scilit:
- New hope for the failing heartThe American Journal of Medicine, 1982
- The multifactorial role of catecholamines in hypertensive cardiac hypertrophyEuropean Heart Journal, 1982
- Hemodynamic actions of prenalterol in severe congestive heart failure due to chronic coronary diseaseAmerican Heart Journal, 1981
- Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failureThe American Journal of Cardiology, 1980
- Combined nitroprusside-dopamine therapy in severe chronic congestive heart failure: Dose-related hemodynamic advantages over single drug infusionsThe American Journal of Cardiology, 1978
- New cardiotonic agents: A search for digitalis substituteLife Sciences, 1978
- Newer catecholamines for treatment of heart failure and shock: An update on dopamine and a first look at dobutamineProgress in Cardiovascular Diseases, 1977
- Dose-related hemodynamic and renal effects of dopamine in congestive heart failureAmerican Heart Journal, 1974
- Effects of Levodopa on Systolic Preejection Period, Blood Pressure, and Heart Rate during Acute and Chronic Treatment of Parkinson's DiseaseCirculation, 1972
- LevodopaDrugs, 1971